A.K. Gupta, N.R. Poulter, S. Eldridge, J. Dobson, M. Caulfield, F.P. Cappuccio, D. Collier, C.J. Griffiths, H. Hemingway, J.K. Cruickshank, P.S. Sever, G.S. Feder Imperial College London, United King.....
Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton General Hospital, Hamilton, Canada. yusufs@mcmaster.caBACKGROUND: Approximately 15.5 million deaths from cardiovascular.....
Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada. smehta@mcmaster.caCONTEXT: Glucose-insulin-potassium (GIK) infusion is a w.....
Context Evidence suggests that more intensive lowering of low-density lipoprotein cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable coronary artery dis.....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in pat.....